2021 Worldwide Decentralized Clinical Trial Insights - Impact of COVID-19 on the Market prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
CASTOR Continues Rapid Growth and Momentum Powering COVID-19 Studies with Global Decentralized Clinical Trial Platform
Castor is supporting more than 250 COVID-19 studies in 40 countries across 1,750 hospitals
- Offers an expanded suite of tools and resources for clinical researchers in the fight against COVID-19 and other pandemic outbreaks
May 26, 2021 07:58 AM Eastern Daylight Time
HOBOKEN, N.J. (BUSINESS WIRE) Castor, a leading provider of clinical trial technology to Democratize Clinical Research, announced today continued rapid adoption of its decentralized clinical trial platform to power COVID-19 studies globally.
At the start of the pandemic, Castor joined the global fight against the COVID-19 by offering its user-friendly, globally scalable Decentralized Clinical Trial (DCT) platform for free for all COVID-19 research projects. Castor is supporting more than 250 COVID-19 studies in 40 countries across 1,750 hospitals. 62,000 participants are enrolled in these trials